Supplementary Material for: Prognostic Factors Across Poorly Differentiated Neuroendocrine Neoplasms: a Pooled Analysis

  • Giovanni Centonze (Contributor)
  • Patrick Maisonneuve (Contributor)
  • Natalie Prinzi (Contributor)
  • Sara Pusceddu (Contributor)
  • Luca Albarello (Contributor)
  • Eleonora Pisa (Contributor)
  • Massimo Barberis (Contributor)
  • Alessandro Vanoli (Contributor)
  • Paola Spaggiari (Contributor)
  • Paola Bossi (Contributor)
  • Laura Cattaneo (Contributor)
  • Giovanna Sabella (Contributor)
  • Enrico Solcia (Contributor)
  • Federica Grillo (Contributor)
  • Giovanna Tagliabue (Contributor)
  • Aldo Scarpa (Contributor)
  • Mauro Papotti (Contributor)
  • Marco Volante (Contributor)
  • Alessandro Mangogna (Contributor)
  • Stefano Ferrero (Contributor)
  • Luigi Rolli (Contributor)
  • Elisa Roca (Contributor)
  • Luisa Bercich (Contributor)
  • Mauro Benvenuti (Contributor)
  • Luca Messerini (Contributor)
  • Frediano Inzani (Contributor)
  • Giancarlo Pruneri (Contributor)
  • Adele Busico (Contributor)
  • Federica Perrone (Contributor)
  • Elena Tamborini (Contributor)
  • Alessio Pellegrinelli (Contributor)
  • Ketevani Kankava (Contributor)
  • Alfredo Berruti (Contributor)
  • Ugo Pastorino (Contributor)
  • Nicola Fazio (Contributor)
  • Fausto Sessa (Contributor)
  • Carlo Capella (Contributor)
  • Guido Rindi (Contributor)
  • Massimo Milione (Contributor)

Dataset

Description

Introduction: Poorly differentiated neuroendocrine carcinomas (NECs) are characterized by aggressive clinical course and poor prognosis. No reliable prognostic markers have been validated to date; thus, the definition of a specific NEC prognostic algorithm represents a clinical need. This study aimed to analyze a large NEC case series to validate the specific prognostic factors identified in previous studies on gastro-entero-pancreatic (GEP) and lung NECs and to assess if further prognostic parameters can be isolated. Methods: A pooled analysis of four NEC retrospective studies was performed to evaluate: the prognostic role of Ki-67 cut-off, the OS according to primary cancer site, and further prognostic parameters using multivariable Cox proportional hazards model and machine-learning random survival forest (RSF). Results: 422 NECs were analyzed. The most represented tumor site was the colorectum (n=156, 37%), followed by the lungs (n=111, 26%), gastroesophageal site (n=83, 20%; 66 gastric, 79%). The Ki-67 index was the most relevant predictor, followed by morphology (pure or mixed/combined NECs), stage, and site. The predicted RSF response for survival at 1, 2, or 3 years showed decreasing survival with increasing Ki-67, pure NEC morphology, stage III–IV, and colorectal NEC disease. Patients with Ki-67
Dati resi disponibili2022
EditoreKarger Publishers

Cita questo